Western blot analysis confirmed the modulation of FGFR4-driven signaling pathways, particularly those involved in epithelial-mesenchymal transition (EMT).<h4>Conclusions</h4>This study successfully identified several CSC-selective membrane antigens that can become therapeutic targets in CRC. Here, FGFR4 is linked to colorectal carcinoma.